National Agri-Marketing Association
NAMA Website
Upcoming Events
Agri-Marketing Conf
Best of NAMA 2017
Member Directory

Source: Arysta LifeScience news release

Arysta LifeScience recently announced that it has entered into a global collaboration with DuPont Crop Protection for the development of new foliar insecticides based on the market-leading product, DuPontTM Rynaxypyr®

The long-term agreement between the two companies allows Arysta LifeScience to combine Rynaxypyr® insect control in premixes with acetamiprid, thereby creating novel insecticidal formulations that more efficiently and conveniently address needs of growers.

"Through our collaboration with DuPont, we are expanding our development of proprietary foliar insecticides for specialty crop protection," said Diego Lopez Casanello, president, Arysta LifeScience. "The premix formulations will control a broader spectrum of pests than straight Rynaxypyr® products, which will increase its utility to growers in many countries around the world."

"Our agreement with Arysta LifeScience increases the value of our investment in Rynaxypyr®, and most importantly, gives growers more tools to effectively manage insects," said Timothy P. Glenn, president, DuPont Crop Protection.

Combining Rynaxypyr® with acetamiprid offers multiple benefits including:

1. Broadening the spectrum of control of Rynaxypyr® with activity on sucking pests such as whiteflies, aphids, certain lepidoptera, and micro-lepidoptera
2. Fit with a broad range of crop segments, including both row and specialty crops
3. Offering flexible application timing suitable for integrated pest management
4. Controlling pests that have become resistant to other products

Search News & Articles

Proudly associated with:
American Business Media Canadian Agri-Marketing Association National Agri-Marketing Association
Agricultural Relations Council National Association of Farm Broadcasters American Agricultural Editors' Association Livestock Publications Council
All content © 2018, Henderson Communications LLC. | User Agreement